other material
confidence high
sentiment neutral
materiality 0.70
Ultragenyx raises ~$330.7M in public offering of common stock and pre-funded warrants
Ultragenyx Pharmaceutical Inc.
- Offering of 7,435,898 shares at $39/share plus pre-funded warrants for 1,538,501 shares at $38.999.
- Net proceeds expected ~$330.7M after underwriting discounts and expenses.
- Underwriters granted 30-day option to purchase up to 1,346,153 additional shares.
- Closing expected June 17, 2024; use of proceeds for general corporate purposes.